STING1 and neoplasm: PMZFNs drive dual therapeutic mechanisms by inducing ferroptosis that directly kills cancer cells while releasing tumor-associated antigens to trigger ICD and activating cGAS -STING, which amplify the efficacy of ICD through interferon-β production and dendritic cell priming [39].